Amazon Allergy Fexofenadine Hydrochloride Tablets Recalled for Failed Impurity Specifications
Amazon-branded Allergy Fexofenadine Hydrochloride Tablets 180 mg are being recalled because testing found an out-of-specification impurity during stability testing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall of a drug product with a quality defect (out-of-specification impurity) detected during stability testing. No illnesses or injuries have been reported, and the hazard is based on testing results rather than actual patient harm. Per the rubric, Class II recalls without reported hospitalization or injury typically score 2 (Moderate).
Plain-English summary
Amazon Allergy Fexofenadine Hydrochloride Tablets, 180 mg/Antihistamine, 24 HR, 30 count bottles are being recalled. The product was manufactured by Perrigo Company PLC in the Czech Republic and distributed by Amazon.com Services LLC nationwide in the USA. Lot #1BR0462 with expiration 10/31/2022 is affected.
The recall was initiated due to failed impurities and degradation specifications. During stability testing, an out-of-specification result was obtained for impurity A, indicating the product did not meet required quality standards.
Consumers in possession of this product should stop use and contact Amazon for instructions on return or disposal. The affected product can be identified by the UPC 3 70030 11466 5 and lot number 1BR0462.
The recalled product
- Product
- amazon, Allergy Fexofenadine Hydrochloride Tablets, 180 mg/Antihistamine, 24 HR, 30 count bottle, Made in the Czech Republic, Distributed by: Amazon.com Services LLC 410 Terry Avenue N. Seattle, WA 98109 UPC 3 70030 11466 5
- Manufacturer
- Perrigo Company PLC
- Category
- Drug — Antihistamine
- Affected units
- 32,232
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 1BR0462
- Exp 10/31/2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 30 recalled by Perrigo Company PLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 30 products in this recall →Related recalls
Same manufacturer · Perrigo Company PLC
See all →- ModerateCareOne Severe Congestion Nasal Spray Recalled Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateEquate Children's Pain and Fever Acetaminophen Suspension Recall
FDA (Drugs) · 2022-03-02
- ModerateEqualine Nasal Oxymetazoline HCl Nasal Spray Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateUP AND UP Childrens Acetaminophen Recall Due to Contaminated Excipient
FDA (Drugs) · 2022-03-02
- ModerateCVS Infant's Grape Acetaminophen Suspension Recalled for Contaminated Excipient
FDA (Drugs) · 2022-03-02
Same hazard · impurity degradation
See all →- Low
- ModerateEsomeprazole Magnesium oral suspension recalled for failed impurity specifications
FDA (Drugs) · 2025-05-28
- HighDiltiazem Hydrochloride extended-release capsules recalled due to failed quality specifications
FDA (Drugs) · 2023-02-08
- ModerateXiidra ophthalmic solution recalled for failed impurity and degradation specifications
FDA (Drugs) · 2022-06-15
- ModerateXiidra Ophthalmic Solution Recalled for Failed Impurity and Degradation Specifications
FDA (Drugs) · 2022-06-15